Cargando…

Potentiation of TRAIL-induced cell death by nonsteroidal anti-inflammatory drug in human hepatocellular carcinoma cells through the ER stress-dependent autophagy pathway

Hepatocellular carcinoma (HCC) is the most commonly diagnosed primary liver malignancy. The limited success with relapse of the disease in HCC therapy is frequently associated with the acquired resistance to anticancer drugs. To develop a strategy and design for overcoming the resistance of HCC cell...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Su-Hoon, Moon, Hyun-Jung, Lee, Young-Shin, Kang, Chi-Dug, Kim, Sun-Hee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388578/ https://www.ncbi.nlm.nih.gov/pubmed/32705218 http://dx.doi.org/10.3892/or.2020.7662

Ejemplares similares

Nonsteroidal Anti-inflammatory Drugs Sensitize CD44-Overexpressing Cancer Cells to Hsp90 Inhibitor Through Autophagy Activation
por: Moon, Hyun-Jung, et al.
Publicado: (2019)

Diclofenac: A Nonsteroidal Anti-Inflammatory Drug Inducing Cancer Cell Death by Inhibiting Microtubule Polymerization and Autophagy Flux
por: Choi, Soohee, et al.
Publicado: (2022)

Potential Role of CD133 Expression in the Susceptibility of Human Liver Cancer Stem-Like Cells to TRAIL
por: Lee, Su-Hoon, et al.
Publicado: (2016)

Niacin alleviates TRAIL-mediated colon cancer cell death via autophagy flux activation
por: Kim, Sung-Wook, et al.
Publicado: (2015)

Autophagy: novel applications of nonsteroidal anti‐inflammatory drugs for primary cancer
por: Yu, Chen, et al.
Publicado: (2017)

High susceptibility of metastatic cells derived from human prostate and colon cancer cells to TRAIL and sensitization of TRAIL-insensitive primary cells to TRAIL by 4,5-dimethoxy-2-nitrobenzaldehyde
por: Kim, Hak-Bong, et al.
Publicado: (2011)

Nonsteroidal Anti-Inflammatory Drug Conjugated with Gadolinium (III) Complex as an Anti-Inflammatory MRI Agent
por: Sung, Bokyung, et al.
Publicado: (2023)

Sensitization of multidrug-resistant cancer cells to Hsp90 inhibitors by NSAIDs-induced apoptotic and autophagic cell death
por: Moon, Hyun-Jung, et al.
Publicado: (2018)

Nonsteroidal Anti-Inflammatory Drug Hypersensitivity in Preschool Children
por: Kidon, Mona Iancovici, et al.
Publicado: (2007)

Nonsteroidal Anti-Inflammatory Drugs, Gastroprotection, and Benefit–Risk
por: Moore, Robert Andrew, et al.
Publicado: (2014)

Nonsteroidal Anti-Inflammatory Drugs and the Kidney
por: Hörl, Walter H.
Publicado: (2010)

Nonsteroidal anti‐inflammatory drugs and pharyngitis
por: Mazzone, Stuart B, et al.
Publicado: (2022)

Topical nonsteroidal anti-inflammatory drugs
por: Bhat, Chirag, et al.
Publicado: (2023)

Reply to Vigilance in Prescribing Nonsteroidal Anti-inflammatory Drugs
por: Seo, Kyoung-Woo, et al.
Publicado: (2017)

Phenotypes of Severe Cutaneous Adverse Reactions Caused by Nonsteroidal Anti-inflammatory Drugs
por: Lee, Suh-Young, et al.
Publicado: (2018)

Patients, their doctors, nonsteroidal anti-inflammatory drugs and the perception of risk
por: Goldkind, Lawrence, et al.
Publicado: (2006)

The regulation of combined treatment-induced cell death with recombinant TRAIL and bortezomib through TRAIL signaling in TRAIL-resistant cells
por: Ryu, Sunhyo, et al.
Publicado: (2018)

Tolerance to etoricoxib in children with nonsteroidal anti-inflammatory drug hypersensitivity
por: Loh, Wenyin, et al.
Publicado: (2015)

Nonsteroidal Anti-Inflammatory Drugs and Risk of Melanoma
por: Jeter, Joanne M., et al.
Publicado: (2011)

Nonsteroidal Anti-Inflammatory Drugs for Retinal Disease
por: Schoenberger, Scott D., et al.
Publicado: (2013)

Nonsteroidal Anti-Inflammatory Drugs and Prostatic Diseases
por: Ishiguro, Hitoshi, et al.
Publicado: (2014)

Vigilance in Prescribing Nonsteroidal Anti-inflammatory Drugs
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2017)

Nonsteroidal anti-inflammatory drugs and their risk: a story still in development
por: Simon, Lee S
Publicado: (2013)

Alzheimer’s Disease Can Be Spared by Nonsteroidal Anti-Inflammatory Drugs
por: McGeer, Patrick L., et al.
Publicado: (2018)

The Toxicity of Nonsteroidal Anti-inflammatory Eye Drops against Human Corneal Epithelial Cells in Vitro
por: Lee, Jong Soo, et al.
Publicado: (2015)

The Combination of TRAIL Treatment and Cancer Cell Selective Expression of TRAIL-Death Receptor DR4 Induces Cell Death in TRAIL-Resistant Cancer Cells
por: Choi, Eunah, et al.
Publicado: (2006)

Preventive Efficacy and Safety of Rebamipide in Nonsteroidal Anti-Inflammatory Drug-Induced Mucosal Toxicity
por: Kim, Jeong Ho, et al.
Publicado: (2014)

ER stress-induced cell death proceeds independently of the TRAIL-R2 signaling axis in pancreatic β cells
por: Hagenlocher, Cathrin, et al.
Publicado: (2022)

Adverse drug reactions of nonsteroidal anti-inflammatory drugs
por: Wiwanitkit, Viroj
Publicado: (2011)

Congenital nephrotic syndrome and nonsteroidal anti-inflammatory drugs
por: Aoun, B., et al.
Publicado: (2012)

Topical Nonsteroidal Anti-Inflammatory Drugs for Macular Edema
por: Russo, Andrea, et al.
Publicado: (2013)

Hypersensitivity Reactions to Nonsteroidal Anti-Inflammatory Drugs: An Update
por: Sánchez-Borges, Mario, et al.
Publicado: (2010)

Clinical Management of Nonsteroidal Anti-inflammatory Drug Hypersensitivity
por: Sánchez-Borges, Mario
Publicado: (2008)

Acute nonsteroidal anti-inflammatory drug-induced colitis
por: Tonolini, Massimo
Publicado: (2013)

Lithium Toxicity in the Setting of Nonsteroidal Anti-Inflammatory Medications
por: Hassan, Syed, et al.
Publicado: (2013)

Risk of stroke associated with nonsteroidal anti-inflammatory drugs
por: Park, Ki, et al.
Publicado: (2014)

Nonsteroidal anti-inflammatory drug hypersensitivity in the Asia-Pacific
por: Thong, Bernard Yu-Hor
Publicado: (2018)

Update on the Management of Nonsteroidal Anti-Inflammatory Drug Hypersensitivity
por: Yeung, Wan Yin Winnie, et al.
Publicado: (2020)

Nonsteroidal anti-inflammatory drugs and glucocorticoids in COVID-19
por: Ricciotti, Emanuela, et al.
Publicado: (2021)

Tristetraprolin Posttranscriptionally Downregulates TRAIL Death Receptors
por: Lee, Won Hyeok, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_gqgr2gqt6cllhmgl7fjnt323mf